Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Daxor Corporation stock logo
DXR
Daxor
$11.66
+5.0%
$10.32
$6.55
$11.70
$53.74M-0.17,609 shs6,000 shs
Intelligent Bio Solutions Inc. stock logo
INBS
Intelligent Bio Solutions
$1.79
+3.5%
$1.66
$1.10
$2.75
$15.53M4.59121,317 shs122,771 shs
PolyPid Ltd. stock logo
PYPD
PolyPid
$3.47
+0.6%
$3.48
$2.30
$3.93
$54.85M1.4856,772 shs26,236 shs
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$3.18
-1.9%
$4.06
$3.03
$9.33
$53.27M1.4183,676 shs43,142 shs
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Daxor Corporation stock logo
DXR
Daxor
+4.95%+5.42%+5.71%+33.26%+27.57%
Intelligent Bio Solutions Inc. stock logo
INBS
Intelligent Bio Solutions
+3.47%+15.48%+18.54%-6.28%-12.25%
PolyPid Ltd. stock logo
PYPD
PolyPid
+0.58%+0.58%-0.57%+1.76%+10.16%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
-1.85%-1.55%-7.02%-33.89%-45.92%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Daxor Corporation stock logo
DXR
Daxor
$11.66
+5.0%
$10.32
$6.55
$11.70
$53.74M-0.17,609 shs6,000 shs
Intelligent Bio Solutions Inc. stock logo
INBS
Intelligent Bio Solutions
$1.79
+3.5%
$1.66
$1.10
$2.75
$15.53M4.59121,317 shs122,771 shs
PolyPid Ltd. stock logo
PYPD
PolyPid
$3.47
+0.6%
$3.48
$2.30
$3.93
$54.85M1.4856,772 shs26,236 shs
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$3.18
-1.9%
$4.06
$3.03
$9.33
$53.27M1.4183,676 shs43,142 shs
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Daxor Corporation stock logo
DXR
Daxor
+4.95%+5.42%+5.71%+33.26%+27.57%
Intelligent Bio Solutions Inc. stock logo
INBS
Intelligent Bio Solutions
+3.47%+15.48%+18.54%-6.28%-12.25%
PolyPid Ltd. stock logo
PYPD
PolyPid
+0.58%+0.58%-0.57%+1.76%+10.16%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
-1.85%-1.55%-7.02%-33.89%-45.92%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Daxor Corporation stock logo
DXR
Daxor
3.00
Buy$25.00114.41% Upside
Intelligent Bio Solutions Inc. stock logo
INBS
Intelligent Bio Solutions
0.00
N/AN/AN/A
PolyPid Ltd. stock logo
PYPD
PolyPid
3.17
Buy$12.40257.35% Upside
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
3.00
Buy$8.00151.57% Upside

Current Analyst Ratings Breakdown

Latest INBS, PYPD, DXR, and SRTS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/14/2025
PolyPid Ltd. stock logo
PYPD
PolyPid
Craig Hallum
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$15.00 ➝ $13.00
8/14/2025
PolyPid Ltd. stock logo
PYPD
PolyPid
Roth Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy
8/13/2025
PolyPid Ltd. stock logo
PYPD
PolyPid
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$13.00
8/12/2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$12.00 ➝ $8.00
8/8/2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
Lake Street Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$13.00 ➝ $6.00
6/18/2025
PolyPid Ltd. stock logo
PYPD
PolyPid
Roth Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price TargetBuy$12.00 ➝ $9.00
6/17/2025
PolyPid Ltd. stock logo
PYPD
PolyPid
JMP Securities
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetMarket Outperform$16.00 ➝ $14.00
(Data available from 9/12/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Daxor Corporation stock logo
DXR
Daxor
N/AN/AN/AN/AN/AN/A
Intelligent Bio Solutions Inc. stock logo
INBS
Intelligent Bio Solutions
$3.05M5.27N/AN/A$0.41 per share4.37
PolyPid Ltd. stock logo
PYPD
PolyPid
N/AN/AN/AN/A$0.75 per shareN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$41.81M1.25$0.42 per share7.50$3.41 per share0.93
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Daxor Corporation stock logo
DXR
Daxor
N/AN/A0.00N/AN/AN/AN/AN/A
Intelligent Bio Solutions Inc. stock logo
INBS
Intelligent Bio Solutions
-$10.57M-$2.05N/A5.11N/A-346.22%-231.13%-108.24%11/6/2025 (Estimated)
PolyPid Ltd. stock logo
PYPD
PolyPid
-$29.02M-$3.83N/AN/AN/A-453.95%-138.92%11/12/2025 (Estimated)
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$6.65M-$0.06N/A13.83N/A-2.26%-1.58%-1.41%11/13/2025 (Estimated)

Latest INBS, PYPD, DXR, and SRTS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/15/2025Q4 2025
Intelligent Bio Solutions Inc. stock logo
INBS
Intelligent Bio Solutions
-$0.12-$0.37-$0.25-$0.41$4.30 million$0.84 million
8/13/2025Q2 2025
PolyPid Ltd. stock logo
PYPD
PolyPid
-$0.53-$0.78-$0.25-$0.78N/AN/A
8/7/2025Q2 2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$0.01-$0.06-$0.07-$0.06$9.30 million$7.32 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Daxor Corporation stock logo
DXR
Daxor
N/AN/AN/AN/AN/A
Intelligent Bio Solutions Inc. stock logo
INBS
Intelligent Bio Solutions
N/AN/AN/AN/AN/A
PolyPid Ltd. stock logo
PYPD
PolyPid
N/AN/AN/AN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Daxor Corporation stock logo
DXR
Daxor
N/AN/AN/A
Intelligent Bio Solutions Inc. stock logo
INBS
Intelligent Bio Solutions
N/A
0.77
0.65
PolyPid Ltd. stock logo
PYPD
PolyPid
N/A
2.28
2.28
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/A
8.14
5.79

Institutional Ownership

CompanyInstitutional Ownership
Daxor Corporation stock logo
DXR
Daxor
1.34%
Intelligent Bio Solutions Inc. stock logo
INBS
Intelligent Bio Solutions
32.97%
PolyPid Ltd. stock logo
PYPD
PolyPid
26.47%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
25.30%

Insider Ownership

CompanyInsider Ownership
Daxor Corporation stock logo
DXR
Daxor
59.50%
Intelligent Bio Solutions Inc. stock logo
INBS
Intelligent Bio Solutions
1.54%
PolyPid Ltd. stock logo
PYPD
PolyPid
24.70%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
8.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
Daxor Corporation stock logo
DXR
Daxor
374.84 million1.96 millionNot Optionable
Intelligent Bio Solutions Inc. stock logo
INBS
Intelligent Bio Solutions
108.98 million8.84 millionNot Optionable
PolyPid Ltd. stock logo
PYPD
PolyPid
8015.90 million11.97 millionNo Data
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
4016.44 million14.98 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Daxor stock logo

Daxor NASDAQ:DXR

$11.66 +0.55 (+4.95%)
As of 09/12/2025 03:54 PM Eastern

Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation is a subsidiary of Estate Of Joseph Feldschuh.

Intelligent Bio Solutions stock logo

Intelligent Bio Solutions NASDAQ:INBS

$1.79 +0.06 (+3.47%)
Closing price 09/12/2025 04:00 PM Eastern
Extended Trading
$1.79 0.00 (0.00%)
As of 09/12/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Intelligent Bio Solutions Inc., a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.

PolyPid stock logo

PolyPid NASDAQ:PYPD

$3.47 +0.02 (+0.58%)
Closing price 09/12/2025 04:00 PM Eastern
Extended Trading
$3.47 0.00 (0.00%)
As of 09/12/2025 06:23 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

PolyPid Ltd., a clinical-stage biopharmaceutical company, developing targeted, locally administered, and prolonged-release therapeutics using its proprietary polymer-lipid encapsulation matrix (PLEX) technology to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in a pivotal Phase 3 confirmatory trial for prevention of surgical site infections (SSIs) in patients undergoing abdominal colorectal surgery with large incisions. It is also developing OncoPLEX, for the treatment of intra-tumoral cancer. PolyPid Ltd. was incorporated in 2008 and is headquartered in Petah Tikva, Israel.

Sensus Healthcare stock logo

Sensus Healthcare NASDAQ:SRTS

$3.18 -0.06 (-1.85%)
Closing price 09/12/2025 04:00 PM Eastern
Extended Trading
$3.18 +0.00 (+0.16%)
As of 09/12/2025 05:28 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, which includes applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.